VASO Corp (VASO) Corporate Subsidiaries
VASO Corp (VASO) is a publicly traded company on the OTC, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VASO
CIK: 839087
Exchange: OTC
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
UHY LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerVin Nguyen
Audit LocationSterling Heights, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090009 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-06 | 2026-07-31 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-086128 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | CURRENT REPORT | 0001213900-26-084076 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-23 | 3 Filing | 0001213900-26-082643 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | CURRENT REPORT | 0001213900-26-080991 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057690 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-04 | CURRENT REPORT | 0001213900-26-053854 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-16 | — | SCHEDULE 13D Filing | 0001213900-26-044358 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-10 | — | SCHEDULE 13D Filing | 0001213900-26-042214 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-037664 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-11 | CURRENT REPORT | 0001213900-26-015515 | View SEC Doc Filr Page |
| 8-K | 2025-12-19 | 2025-12-17 | CURRENT REPORT | 0001213900-25-123593 | View SEC Doc Filr Page |
| DEFA14A | 2025-11-26 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-115366 | View SEC Doc Filr Page |
| 8-K | 2025-11-20 | 2025-11-19 | CURRENT REPORT | 0001213900-25-112966 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-110955 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-05 | 2025-12-17 | PROXY STATEMENT | 0001213900-25-106419 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | QUARTERLY REPORT | 0001213900-25-076616 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | QUARTERLY REPORT | 0001213900-25-044213 | View SEC Doc Filr Page |
| 10-K | 2025-03-31 | 2024-12-31 | ANNUAL REPORT | 0001213900-25-026337 | View SEC Doc Filr Page |
| 8-K | 2025-01-03 | 2025-01-01 | CURRENT REPORT | 0001213900-25-000753 | View SEC Doc Filr Page |
| 4 | 2024-11-22 | 2024-11-21 | 4 Filing | 0001213900-24-101467 | View SEC Doc Filr Page |
| 4 | 2024-11-19 | 2024-11-15 | 4 Filing | 0001213900-24-100161 | View SEC Doc Filr Page |
| 10-Q | 2024-11-14 | 2024-09-30 | QUARTERLY REPORT | 0001213900-24-098378 | View SEC Doc Filr Page |
| 8-K | 2024-09-19 | 2024-09-17 | CURRENT REPORT | 0001213900-24-079992 | View SEC Doc Filr Page |
| 425 | 2024-09-10 | — | CURRENT REPORT | 0001213900-24-077422 | View SEC Doc Filr Page |